We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Researchers Discover New Vulnerability in Deadly Form of Lung Cancer

Video   Jul 04, 2018 | UT Southwestern, YouTube

 

Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in small cell lung cancer (SCLC) that can be targeted by existing drug therapies.

SCLC is a deadly and aggressive form of lung cancer with few therapeutic options and an incredibly low five-year survival rate of 5 percent. Researchers at CRI believe the key to finding new therapies for this disease lies in better understanding the metabolism of SCLC.

This content has been republished from materials provided by UT Southwestern. Note: material may have been edited for length and content. For further information, please contact the cited source.

 
More Information
 
 
 

Recommended Videos

Cell Fates - Division, Senescence and Death

Video

In this video, learn about the fates of a cell.

WATCH NOW

A "Living Drug" That Could Change the Way We Treat Cancer

Video

In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.

WATCH NOW

CAR T-cell Therapy: Reprogramming the Immune System To Treat Cancer

Video

Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE